Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $22.43 in the prior trading day, Viridian Therapeutics Inc (NASDAQ: VRDN) closed at $22.48, up 0.22%. In other words, the price has increased by $0.22 from its previous closing price. On the day, 1.27 million shares were traded. VRDN stock price reached its highest trading level at $23.74 during the session, while it also had its lowest trading level at $22.415.
Ratios:
Our goal is to gain a better understanding of VRDN by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 15.82 and its Current Ratio is at 15.82. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.03.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Needham on September 11, 2024, Reiterated its Buy rating but revised its target price to $38 from $30 previously.
On June 11, 2024, Wolfe Research started tracking the stock assigning a Outperform rating and target price of $29.
On June 06, 2024, Goldman started tracking the stock assigning a Buy rating and target price of $23.Goldman initiated its Buy rating on June 06, 2024, with a $23 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 27 ’24 when Beetham Thomas W. bought 5,000 shares for $23.41 per share. The transaction valued at 117,050 led to the insider holds 6,000 shares of the business.
Mahoney Stephen F. bought 21,400 shares of VRDN for $499,262 on Sep 27 ’24. The President and CEO now owns 21,400 shares after completing the transaction at $23.33 per share. On Sep 13 ’24, another insider, Fairmount Funds Management LLC, who serves as the Director of the company, bought 1,600,000 shares for $18.75 each. As a result, the insider paid 30,000,000 and bolstered with 3,445,813 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VRDN now has a Market Capitalization of 1780701568 and an Enterprise Value of 1083999872. For the stock, the TTM Price-to-Sale (P/S) ratio is 5721.66 while its Price-to-Book (P/B) ratio in mrq is 3.11. Its current Enterprise Value per Revenue stands at 3763.889 whereas that against EBITDA is -4.332.
Stock Price History:
Over the past 52 weeks, VRDN has reached a high of $27.20, while it has fallen to a 52-week low of $11.40. The 50-Day Moving Average of the stock is 0.57%, while the 200-Day Moving Average is calculated to be 31.09%.
Shares Statistics:
The stock has traded on average 1.44M shares per day over the past 3-months and 1223090 shares per day over the last 10 days, according to various share statistics. A total of 76.36M shares are outstanding, with a floating share count of 67.61M. Insiders hold about 11.45% of the company’s shares, while institutions hold 83.60% stake in the company. Shares short for VRDN as of 1728950400 were 9791768 with a Short Ratio of 6.93, compared to 1726185600 on 10461877. Therefore, it implies a Short% of Shares Outstanding of 9791768 and a Short% of Float of 14.64.
